<DOC>
	<DOCNO>NCT01042873</DOCNO>
	<brief_summary>A decrease response beta 1 adrenergic receptor agonist ( desensitization ) think play major role pathogenesis diseases congestive heart failure . However , currently , vivo model enable u measure desensitization hemodynamic response beta 1 adrenergic receptor vivo . Our hypothesis constant 3 hour intravenous infusion selective beta1 adrenergic receptor agonist dobutamine result gradual decline hemodynamic response dobutamine time .</brief_summary>
	<brief_title>The Hemodynamic Response Prolonged Dobutamine Infusion</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>healthy subject consumption medication 2 week prior study history chest pain tachycardia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Desensitization</keyword>
	<keyword>beta adrenergic receptor</keyword>
	<keyword>Healthy subject</keyword>
</DOC>